Plaisance P, Pirracchio R, Berton Christine, Vicaut Eric, Payen D
Department of Anaesthesiology and Critical Care, Lariboisière University Hospital AP-HP, 2 Rue Ambroise Paré, Paris 75010, France.
Eur Heart J. 2007 Dec;28(23):2895-901. doi: 10.1093/eurheartj/ehm502. Epub 2007 Oct 29.
In acute cardiogenic pulmonary oedema (ACPE), continuous positive airway pressure (CPAP) added to medical treatment improves outcome. The present study was designed to assess the benefit of CPAP as a first line treatment of ACPE in the out-of-hospital environment.
The protocol lasted 45 min, divided into three periods of 15 min. Patients with ACPE were randomly assigned in two groups: 1/Early CPAP (n = 63): CPAP alone (T0-T15); CPAP + medical treatment (T15-T30); medical treatment alone (T30-T45) and 2/Late CPAP (n = 61): medical treatment alone (T0-T15); medical treatment + CPAP (T15-T30); medical treatment alone (T30-T45). Primary endpoint: effect of early CPAP on a dyspnoea clinical score and on arterial blood gases. Secondary endpoints: incidence of tracheal intubation, inotropic support, and in-hospital mortality. T0-T15: CPAP alone had a greater effect than medical treatment on the clinical score (P = 0.0003) and on PaO(2) (P = 0.0003). T15-T30: adding CPAP to medical treatment (late CPAP group) improved clinical score and blood gases and the two groups were no longer different at T30. T30-T45: in both groups, CPAP withdrawal worsened clinical score. Six patients in 'early CPAP' group vs. 16 in 'late CPAP' group were intubated [P = 0.01, odds-ratio: OR = 0.30 (0.09-0.89)]. Dobutamine was used only in the 'late CPAP' group (n = 5), (P = 0.02). Hospital death was higher in 'late CPAP' group (n = 8) than in 'early CPAP' group (n = 2) [P = 0.05, OR = 0.22 (0.04-1.0)].
When compared to usual medical care, immediate application of CPAP alone in out-of-hospital treatment of ACPO is significantly better improving physiological variables and symptoms and significantly reduces tracheal intubation incidence and in-hospital mortality.
在急性心源性肺水肿(ACPE)中,在药物治疗基础上加用持续气道正压通气(CPAP)可改善预后。本研究旨在评估在院外环境中CPAP作为ACPE一线治疗的益处。
该方案持续45分钟,分为三个15分钟的时间段。ACPE患者被随机分为两组:1/早期CPAP组(n = 63):仅CPAP(T0 - T15);CPAP + 药物治疗(T15 - T30);仅药物治疗(T30 - T45)和2/晚期CPAP组(n = 61):仅药物治疗(T0 - T15);药物治疗 + CPAP(T15 - T30);仅药物治疗(T30 - T45)。主要终点:早期CPAP对呼吸困难临床评分和动脉血气的影响。次要终点:气管插管发生率、使用血管活性药物支持情况及住院死亡率。T0 - T15:仅CPAP在临床评分(P = 0.0003)和动脉血氧分压(PaO₂,P = 0.0003)方面比药物治疗效果更好。T15 - T30:在药物治疗基础上加用CPAP(晚期CPAP组)改善了临床评分和血气,两组在T30时不再有差异。T30 - T45:两组中,停用CPAP均使临床评分恶化。“早期CPAP”组有6例患者插管,“晚期CPAP”组有16例患者插管[P = 0.01,优势比:OR = 0.30(0.09 - 0.89)]。多巴酚丁胺仅在“晚期CPAP”组使用(n = 5),(P = 0.02)。“晚期CPAP”组的住院死亡率(n = 8)高于“早期CPAP”组(n = 2)[P = 0.05,OR = 0.22(0.04 - 1.0)]。
与常规药物治疗相比,在院外治疗ACPO时立即单独应用CPAP能显著更好地改善生理指标和症状,并显著降低气管插管发生率和住院死亡率。